AG Ventures Ltd
Incorporated in 1978, Oriental Carbon & Chemicals Ltd sells Chemicals (Insoluble Sulphur, Sulphuric acid) and has other Investments[1]
- Market Cap ₹ 128 Cr.
- Current Price ₹ 128
- High / Low ₹ 330 / 104
- Stock P/E 29.3
- Book Value ₹ 255
- Dividend Yield 0.00 %
- ROCE -0.62 %
- ROE 1.10 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.48 times its book value
- Company is expected to give good quarter
- Market value of investments Rs.132 Cr. is more than the Market Cap Rs.124 Cr.
Cons
- The company has delivered a poor sales growth of -41.9% over past five years.
- Tax rate seems low
- Company has a low return on equity of 3.53% over last 3 years.
- Earnings include an other income of Rs.2.06 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 261.70 | 282.58 | 271.03 | 297.41 | 323.82 | 383.29 | 339.90 | 341.05 | 386.36 | 463.23 | 14.86 | 22.54 | 30.16 | |
| 192.92 | 210.14 | 189.36 | 208.13 | 224.13 | 260.67 | 240.96 | 218.71 | 307.71 | 366.46 | 44.80 | 25.27 | 27.14 | |
| Operating Profit | 68.78 | 72.44 | 81.67 | 89.28 | 99.69 | 122.62 | 98.94 | 122.34 | 78.65 | 96.77 | -29.94 | -2.73 | 3.02 |
| OPM % | 26.28% | 25.64% | 30.13% | 30.02% | 30.79% | 31.99% | 29.11% | 35.87% | 20.36% | 20.89% | -201.48% | -12.11% | 10.01% |
| 2.86 | 11.70 | 5.09 | 5.60 | 4.13 | 6.80 | 9.57 | 1.64 | 7.36 | 1.49 | 77.27 | -358.27 | 2.06 | |
| Interest | 11.05 | 8.10 | 6.35 | 5.01 | 7.85 | 8.25 | 9.16 | 6.35 | 8.16 | 12.84 | 0.01 | 0.01 | 0.13 |
| Depreciation | 10.43 | 13.08 | 15.65 | 15.15 | 16.34 | 18.59 | 20.05 | 20.98 | 23.00 | 27.93 | 1.52 | 1.52 | 1.49 |
| Profit before tax | 50.16 | 62.96 | 64.76 | 74.72 | 79.63 | 102.58 | 79.30 | 96.65 | 54.85 | 57.49 | 45.80 | -362.53 | 3.46 |
| Tax % | 19.36% | 18.49% | 18.19% | 27.49% | 28.73% | 28.11% | 9.84% | 22.40% | 27.16% | 23.97% | -1.09% | 1.05% | |
| 40.44 | 51.32 | 52.99 | 54.17 | 56.75 | 73.74 | 71.51 | 75.00 | 39.95 | 43.71 | 46.29 | -366.34 | 4.37 | |
| EPS in Rs | 39.26 | 49.83 | 51.45 | 52.59 | 55.10 | 73.74 | 71.51 | 75.00 | 39.95 | 43.71 | 46.29 | -366.34 | 4.37 |
| Dividend Payout % | 17.85% | 17.08% | 16.54% | 19.03% | 18.17% | 16.29% | 14.00% | 18.69% | 35.01% | 32.00% | 30.21% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -22% |
| 5 Years: | -42% |
| 3 Years: | -61% |
| TTM: | 117% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -21% |
| 5 Years: | -41% |
| 3 Years: | -50% |
| TTM: | 45% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -11% |
| 3 Years: | -15% |
| 1 Year: | -52% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 6% |
| 3 Years: | 4% |
| Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10.31 | 10.31 | 10.31 | 10.31 | 10.31 | 10.01 | 10.01 | 10.01 | 9.99 | 9.99 | 9.99 | 9.99 | 9.99 |
| Reserves | 193.55 | 233.87 | 276.33 | 332.57 | 377.50 | 403.53 | 457.97 | 522.54 | 547.10 | 583.69 | 615.67 | 243.29 | 245.24 |
| 103.88 | 90.65 | 72.62 | 102.62 | 117.32 | 125.11 | 153.62 | 184.71 | 187.88 | 165.20 | 0.00 | 0.00 | 24.97 | |
| 48.66 | 56.28 | 58.07 | 61.91 | 67.63 | 73.26 | 57.48 | 73.88 | 86.30 | 78.47 | 216.30 | 12.38 | 9.80 | |
| Total Liabilities | 356.40 | 391.11 | 417.33 | 507.41 | 572.76 | 611.91 | 679.08 | 791.14 | 831.27 | 837.35 | 841.96 | 265.66 | 290.00 |
| 193.43 | 187.58 | 182.82 | 306.10 | 308.34 | 344.35 | 338.32 | 326.89 | 437.46 | 461.64 | 53.49 | 50.07 | 113.12 | |
| CWIP | 2.27 | 4.17 | 39.51 | 2.52 | 40.36 | 3.33 | 25.32 | 113.38 | 41.34 | 1.47 | 0.00 | 0.00 | 0.00 |
| Investments | 25.86 | 41.31 | 30.19 | 52.94 | 75.81 | 107.81 | 147.44 | 198.87 | 186.63 | 216.57 | 237.21 | 208.80 | 170.19 |
| 134.84 | 158.05 | 164.81 | 145.85 | 148.25 | 156.42 | 168.00 | 152.00 | 165.84 | 157.67 | 551.26 | 6.79 | 6.69 | |
| Total Assets | 356.40 | 391.11 | 417.33 | 507.41 | 572.76 | 611.91 | 679.08 | 791.14 | 831.27 | 837.35 | 841.96 | 265.66 | 290.00 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.53 | 69.97 | 68.40 | 77.13 | 86.70 | 88.51 | 107.79 | 85.05 | 51.73 | 90.66 | 97.50 | 1.55 | |
| -23.24 | -31.39 | -42.06 | -83.87 | -71.55 | -45.00 | -82.83 | -123.48 | -32.08 | -38.25 | -44.83 | 16.55 | |
| -31.69 | -31.56 | -35.02 | 4.71 | -7.33 | -51.37 | -3.39 | 16.71 | -20.78 | -52.40 | -52.73 | -17.02 | |
| Net Cash Flow | -3.40 | 7.02 | -8.68 | -2.03 | 7.82 | -7.86 | 21.57 | -21.73 | -1.13 | 0.01 | -0.05 | 1.08 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 65.72 | 66.51 | 64.71 | 93.98 | 85.19 | 79.67 | 71.59 | 80.05 | 76.30 | 59.55 | 0.00 | 0.00 |
| Inventory Days | 203.87 | 159.85 | 203.94 | 167.92 | 185.09 | 164.00 | 138.42 | 176.59 | 147.48 | 123.84 | 0.00 | |
| Days Payable | 72.69 | 65.85 | 53.85 | 94.58 | 90.41 | 62.68 | 58.32 | 84.29 | 62.14 | 38.87 | ||
| Cash Conversion Cycle | 196.90 | 160.50 | 214.80 | 167.33 | 179.87 | 180.98 | 151.70 | 172.36 | 161.64 | 144.51 | 0.00 | 0.00 |
| Working Capital Days | 33.53 | 23.15 | 27.28 | 54.27 | 39.85 | 46.09 | 32.05 | 92.01 | 92.63 | 82.73 | 8,226.50 | 9.88 |
| ROCE % | 20.68% | 22.48% | 20.58% | 20.11% | 18.45% | 21.51% | 14.68% | 15.44% | 8.29% | 9.45% | -4.53% | -0.62% |
Documents
Announcements
- Outcome Of Board Meeting Dated 12.11.2025 12 Nov
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On November 12, 2025
12 Nov - Board approved Q2 FY26 results; Rs37,494.57 lakh exceptional loss from demerged chemicals business; limited review completed.
-
Announcement under Regulation 30 (LODR)-Cessation
6 Nov - Nominee Director Mr. Sanjay Verma ceased on November 06, 2025 after completing three-year tenure.
-
Announcement under Regulation 30 (LODR)-Change in Directorate
6 Nov - Nominee Director Sanjay Verma ceased w.e.f. closure of business hours on November 06, 2025.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
6 Nov - Listing Regulations, please find enclosed the copies of notices to general public by way of advertisements published today i.e. 06.11.2025 (Thursday) in the newspapers namely …
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023TranscriptPPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT REC
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jun 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020TranscriptAI SummaryPPT
-
Aug 2020TranscriptAI SummaryPPT
-
Jun 2020TranscriptAI SummaryPPT
-
Jan 2020TranscriptAI SummaryPPT
-
Oct 2019TranscriptAI SummaryPPT
-
Jul 2019TranscriptAI SummaryPPT
-
May 2019TranscriptAI SummaryPPT
-
Feb 2019TranscriptAI SummaryPPT
-
Nov 2018TranscriptAI SummaryPPT
-
Jul 2018TranscriptAI SummaryPPT
-
May 2018TranscriptAI SummaryPPT
-
Feb 2018TranscriptAI SummaryPPT
-
Nov 2017TranscriptAI SummaryPPT
-
Jul 2017TranscriptAI SummaryPPT
-
May 2017TranscriptAI SummaryPPT
-
May 2017TranscriptAI SummaryPPT
-
Feb 2017TranscriptAI SummaryPPT
-
Nov 2016TranscriptAI SummaryPPT
-
Jul 2016TranscriptAI SummaryPPT
-
Dec 2015TranscriptAI SummaryPPT
Business Overview:[1][2]
OCCL belongs to the Duncan JP Goenka Group of Companies. It is an ISO40001 and ISO45001 certified manufacturer of customised and value added grades of Insoluble Sulphur.